Apyx Medical Statistics

Total Valuation

Apyx Medical has a market cap or net worth of $161.66 million. The enterprise value is $175.73 million.

Market Cap	161.66M
Enterprise Value	175.73M

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Apyx Medical has 41.03 million shares outstanding. The number of shares has increased by 15.78% in one year.

Current Share Class	41.03M
Shares Outstanding	41.03M
Shares Change (YoY)	+15.78%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	13.41%
Owned by Institutions (%)	22.31%
Float	28.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.30
Forward PS	2.93
PB Ratio	25.48
P/TBV Ratio	27.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.44, with a Debt / Equity ratio of 6.45.

Current Ratio	4.44
Quick Ratio	3.47
Debt / Equity	6.45
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.63

Financial Efficiency

Return on equity (ROE) is -168.13% and return on invested capital (ROIC) is -12.46%.

Return on Equity (ROE)	-168.13%
Return on Assets (ROA)	-10.06%
Return on Invested Capital (ROIC)	-12.46%
Return on Capital Employed (ROCE)	-20.49%
Revenue Per Employee	$217,736
Profits Per Employee	-$66,091
Employee Count	220
Asset Turnover	0.81
Inventory Turnover	1.97

Taxes

In the past 12 months, Apyx Medical has paid $265,000 in taxes.

Income Tax	265,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +154.19% in the last 52 weeks. The beta is 1.49, so Apyx Medical's price volatility has been higher than the market average.

Beta (5Y)	1.49
52-Week Price Change	+154.19%
50-Day Moving Average	3.33
200-Day Moving Average	2.08
Relative Strength Index (RSI)	56.63
Average Volume (20 Days)	160,319

Short Selling Information

The latest short interest is 279,717, so 0.68% of the outstanding shares have been sold short.

Short Interest	279,717
Short Previous Month	362,649
Short % of Shares Out	0.68%
Short % of Float	0.97%
Short Ratio (days to cover)	2.25

Income Statement

In the last 12 months, Apyx Medical had revenue of $47.90 million and -$14.54 million in losses. Loss per share was -$0.36.

Revenue	47.90M
Gross Profit	30.01M
Operating Income	-9.51M
Pretax Income	-14.26M
Net Income	-14.54M
EBITDA	-8.93M
EBIT	-9.51M
Loss Per Share	-$0.36

Full Income Statement

Balance Sheet

The company has $25.14 million in cash and $39.21 million in debt, giving a net cash position of -$14.08 million or -$0.34 per share.

Cash & Cash Equivalents	25.14M
Total Debt	39.21M
Net Cash	-14.08M
Net Cash Per Share	-$0.34
Equity (Book Value)	6.08M
Book Value Per Share	0.15
Working Capital	37.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.41 million and capital expenditures -$1.08 million, giving a free cash flow of -$9.49 million.

Operating Cash Flow	-8.41M
Capital Expenditures	-1.08M
Free Cash Flow	-9.49M
FCF Per Share	-$0.23

Full Cash Flow Statement

Margins

Gross margin is 62.65%, with operating and profit margins of -19.84% and -30.35%.

Gross Margin	62.65%
Operating Margin	-19.84%
Pretax Margin	-29.77%
Profit Margin	-30.35%
EBITDA Margin	-18.64%
EBIT Margin	-19.84%
FCF Margin	n/a

Dividends & Yields

Apyx Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.78%
Shareholder Yield	-15.78%
Earnings Yield	-8.99%
FCF Yield	-5.87%

Analyst Forecast

The average price target for Apyx Medical is $8.00, which is 103.05% higher than the current price. The consensus rating is "Buy".

Price Target	$8.00
Price Target Difference	103.05%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	39.94%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 6, 1994. It was a reverse split with a ratio of 1:15.

Last Split Date	Jan 6, 1994
Split Type	Reverse
Split Ratio	1:15

Scores

Apyx Medical has an Altman Z-Score of -0.37 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.37
Piotroski F-Score	3